Advances in the Diagnosis and Management of Multiple Sclerosis
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
2
Tolebrutinib Approved in EU for Nonrelapsing Secondary Progressive MS, Marking First Disability-Targeting Therapy in the Indication
3
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
4
New Deep Learning Tool Forecasts Alzheimer Disease Progression From Baseline MRI
5